Yahoo Search Búsqueda en la Web

Entrar

Resultado de búsqueda

  1. www.vademecum.com › medicamentos › riluzol-sandozRiluzol Sandoz (50 mg) - Comprimido recubierto con película

    15 de may. de 2024 · Descripción Medicamento. Qué es Riluzol Sandoz El principio activo de Riluzol Sandoz es riluzol que actúa sobre el sistema nervioso. Para qué se utiliza Riluzol Sandoz Riluzol Sandoz se utiliza en pacientes con esclerosis lateral amiotrófica (ELA).

  2. fadavisat.mhmedical.com › contentRiluzole | Davis's Drug Guide for Rehabilitation ...

    4 de may. de 2024 · riluzole (ril-yoo-zole) Rilutek. Classification. Therapeutic: agents for amyotrophic lateral sclerosis. Pharmacologic: glutamate antagonist + + +

  3. www.vademecum.com › medicamentos › paroex-29501Paroex (1, 2 mg/ml) - Solución para enjuague bucal - Vademecum

    15 de may. de 2024 · Paroex. 1, 2 mg/ml. Medicamento en forma farmaceútica de tipo solución para enjuague bucal, se administra por vía bucal, compuesto por 0.6360 g del principio activo Clorhexidina digluconato. Contiene los excipientes Glicerol (1.5070g), Acesulfamo potásico (0.1206g), Macrogolglicerol, hidroxiestearato de (1.000g), Propilenglicol (2.000g ...

  4. myhealthbox.eu › en › teglutikTEGLUTIK 5 mg/ml oral | myHealthbox

    23 de may. de 2024 · riluzole. Dosage: 5mg/ml. Pharmaceutical form: Oral suspension. Administration route: oral use. Units in package: 300 mL. Prescription type: POM - Prescription Only Medicine. Manufactured by: ITALFARMACO S.A. Therapeutic group: other nervous system drugs. Therapeutic indications:

  5. Videos

    Ver todo

  6. jchr.org › index › JCHRExploring the Potential of Riluzole in Stimulating Brain ...

    14 de may. de 2024 · Riluzole, known for its ability to lower extracellular glutamate levels and increase BDNF expression, has emerged as a potential antidepressant agent. The investigation aims to elucidate whether riluzole treatment can directly stimulate the release of BDNF from human platelets at therapeutic concentrations.

  7. mndnsw.asn.au › 229-riluzoleRiluzole - mndnsw.asn.au

    8 de may. de 2024 · Riluzole is prescribed for the treatment of amyotrophic lateral sclerosis (ALS) and progressive bulbar palsy (PBP) – the most common types of MND. Riluzole does not cure motor neurone disease but research shows it can slow the progression of MND and may increase life expectancy by as much as 19 months, so it is still the most ...

  8. Imágenes

    • Riluzole (Sun Pharmaceutical Industries, Inc.): FDA Package Insert
    • Actavis adds riluzole tablets to generics range | Chemist+Druggist

    Ver todo

  9. cora.ucc.ie › server › apiThe Impact of Riluzole on Neurobehavioral Outcomes in ...

    3 de may. de 2024 · Conclusion: In preclinical models of traumatic and nontraumatic SCI, riluzole significantly improves locomotor scores, gait function, and neuropathic pain. This review provides the background information necessary to interpret the results of clinical trials on the impact of riluzole in traumatic and nontraumatic SCI. Keywords